Deals
European Activist Investor Bluebell Capital to Shut Hedge Fund
- Fund wasn’t large enough to justify its administrative costs
- Firm to return capital to external investors and restructure
London-based Bluebell is returning capital to external investors from its co-mingled fund.
Photographer: Chris Ratcliffe/BloombergThis article is for subscribers only.
Bluebell Capital Partners, the European activist investment firm, is shutting down its hedge fund after targeting high-profile companies from pharmaceutical giant GSK Plc to luxury conglomerate Richemont.
London-based Bluebell is returning capital to external investors from its co-mingled fund and will restructure the firm, co-founder Giuseppe Bivona said in response to Bloomberg queries Monday. It will continue to pursue its activist strategy through co-investments and advisory mandates, Bivona said.